Second Complete Remission of Relapsed Stage IV Non-Small Cell Lung Cancer Following Retreatment

Non-small cell lung cancer (NSCLC) is the leading cause of cancer related deaths. Most patients were presented with advanced disease at the time of diagnosis. In advanced NSCLC, it is almost impossible to anticipate complete remission by using only cytotoxic chemotherapy or molecularly targeted agen...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Su Jin, Lee, Jeong Eun, Jung, Sun Young, Park, Dong Il, Park, Myoung Rin, Park, Hee Sun, Jung, Sung Soo, Kim, Ju Ock, Kim, Sun Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510290/
https://www.ncbi.nlm.nih.gov/pubmed/23227080
http://dx.doi.org/10.4046/trd.2012.72.4.381
Descripción
Sumario:Non-small cell lung cancer (NSCLC) is the leading cause of cancer related deaths. Most patients were presented with advanced disease at the time of diagnosis. In advanced NSCLC, it is almost impossible to anticipate complete remission by using only cytotoxic chemotherapy or molecularly targeted agents. In our case, two patients were diagnosed as advanced NSCLC and received chemotherapy. They achieved complete response (CR). After finishing treatment, disease recurred. They were retreated with the same regimens and achieved second CR. Until now, they have received each regimen, continuously, and the CR state has been maintained.

Ejemplares similares